Navigation Links
Boston Scientific Announces Schedule for EuroPcr 2007

Scientific Corporation

CONTACT: Paul Donovan, Media Relations, +1-508-650-8541 (office),+1-508-667-5165 (mobile), or Dan Brennan, Investor Relations,+1-508-650-8538 (office), +1-617-459-2703 (mobile), both of BostonScientific Corporation

Web site: http://www.bostonscientific.com/

Ticker Symbol: (NYSE:BSX)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
4. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
5. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
6. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
7. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
8. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
9. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
10. Inspire Announces Presentations at Two European Scientific Conferences
11. HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Boston Scientific Announces Schedule for EuroPcr
(Date:12/1/2008)...icy , , ROCHESTER, Minn., Dec. 1 /PRNewswi...ds the use of the drug therapy etanercept ineffect...ammation of the liver caused by excessive consumpt...shed in the December issue of Gastroenterology (...O ALERT: Additional audio and video resources, inc...
(Date:12/1/2008)...ay, December 9 at 11:00 am ET to Discuss Phase 2 S...ISCO, Calif., Dec. 1 S...biopharmaceutical company focused on the developme...ics, today announced new data from its studies of ...presented during the 50th American Society of Hema...
(Date:11/30/2008)...e-USNewswire/ -- Older adults who exercise regular...r number of small blood vessels in the brain, acco...eting of the Radiological Society of North America...University of North Carolina ( UNC) - Chapel Hill...ults who exercise to brain scans of those who do n...
(Date:11/28/2008)...tCall/ -- Eli Lilly and Company,(NYSE: LLY ) ha...(sNDA) from,the U.S. Food and Drug Administration...anagement of chronic pain. Lilly plans to resubmit...g data from a recently completed positive study,i... The decision does not affect duloxetine,s FDA-ap...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Barr Announces Approval of Generic Yasmin 28R 29 5282 1Barr Announces Approval of Generic Yasmin 28R 29 5282 2Barr Announces Approval of Generic Yasmin 28R 29 5282 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 1New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 5New Class of Drugs Might Treat Many Conditions 18938 1New Class of Drugs Might Treat Many Conditions 18938 2Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 1Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 2Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 3
...e Skeletal Muscle More,Efficiently than Male Cells...e stem cells,derived from muscle have a greater ab...le cells, according to a study at Children,s,Hospi...eing published in the April 9 issue of the,Journal...fference,in regenerative capabilities of muscle st...
...007 - Inotek,Pharmaceuticals Corporation announced...eclinical animal data showing that the,administrat...tor,has a large protective effect on the survival ... a nuclear enzyme that directs the,repair of damag...epair enzymes and has potential applications for t...
Other Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 2Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 3
(Date:12/2/2008)...unces integration of its,HealthURL Appliance with...are,Organizations. The EMC Open Systems Archive S...odular DICOM-compliant management platform that,a...uding medical images from,clinical and business a...ntegration with the MedCommons appliance unifies t...
(Date:12/2/2008)...onse Biomedical Corporation (TSX: RBM, OTCBB: RPBI... the Company,s RAMP(R) test to detect Respiratory ...linical study is expected to be used to support a ...n (FDA) and other regulatory jurisdictions for mar...or clinical use. The study is designed to demonstr...
(Date:12/2/2008)...Over Next Decade, According to a New Report from D...2 Decision Resources, one of the w...rmaceutical and healthcare issues, finds that the ...ust growth in the United States over the next deca...e new special report entitled Cellular Therapies,...
(Date:12/2/2008)...l/ -- China Sky One Medical,Inc. ("China Sky One...eading,fully integrated pharmaceutical company pr...public of China ("PRC"), announced today that Mr. ... Officer and Secretary and will,also serve on the... Zhang, who,had served as interim CFO since June,...
Breaking Medicine News(10 mins):Health News:MedCommons HealthURL, a New Unified Clinical Viewer Appliance, Is Integrated with EMC Open Systems Archive Solution for Healthcare Organizations 2Health News:MedCommons HealthURL, a New Unified Clinical Viewer Appliance, Is Integrated with EMC Open Systems Archive Solution for Healthcare Organizations 3Health News:Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial 2Health News:Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial 3Health News:Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial 4Health News:Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017 2Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 2Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 3
... cancer survivors can halve the risk of dying from...se moderately regardless of their weight, suggest...er at the University of California, San Diego (UCS...nical Oncology, this is the first study to look at...
...chers at USC and Caltech have spectacularly slowed...ows general promise in pharmaceutical development ...ut how to make the fruit fly live longer. But the...have something for humans. As reported online in N...
...te Cancer is the most frequently diagnosed cancer ...th prostate cancer this year alone, and more than ...s Month, and with Fathers Day approaching, its a g... prostates healthy and be proactive about cancer p...
...ate department of Health today confirmed the death... virus. This is the first case in 2007 and it see... record number 177 people died due to the virus. ...West Nile this year, while no other state has had ...
Other Medicine News:Health News:Healthy Diet, Exercise can Halve the Risk of Mortality in Breast Cancer Survivors 2Health News:Super Fruit Fly may Harbor Hope for Human Longevity 2Health News:Tips to Maintain a Healthy Prostate 2Health News:First Case of West Nile Virus Death in Madison County 2
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
Small, comes in a compact carrying case, carrying pouch included.
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure.
Medicine Products: